Gene: ATAD3B
Official Full Name: ATPase family AAA domain containing 3Bprovided by HGNC
Gene Summary: The protein encoded by this gene is localized to the mitochondrial inner membrane, where it can bind to a highly-related protein, ATAD3A. ATAD3A appears to interact with matrix nucleoid complexes, and the encoded protein negatively regulates that interaction. This gene is expressed almost exclusively in pluripotent embryonic stem cells and some cancer cells. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO25352 | ATAD3B Knockout cell line (HeLa) | Human | ATAD3B | 1:3~1:6 | Negative | Online Inquiry |
KO25353 | ATAD3B Knockout cell line (HCT 116) | Human | ATAD3B | 1:2~1:4 | Negative | Online Inquiry |
KO25354 | ATAD3B Knockout cell line (HEK293) | Human | ATAD3B | 1:3~1:6 | Negative | Online Inquiry |
ATAD3B Gene Knockout Cell Lines are genetically engineered cell lines that have had the ATAD3B gene selectively disrupted, facilitating the study of mitochondrial biology and cellular metabolism. ATAD3B, a member of the ATPase family, plays a crucial role in mitochondrial dynamics and the maintenance of mitochondrial DNA. By creating knockout cell lines, researchers can eliminate the expression of this gene to elucidate its functions and implications in various physiological and pathological contexts.
These knockout cell lines function through a targeted approach, utilizing CRISPR-Cas9 technology to introduce precise mutations in the ATAD3B locus, resulting in a complete loss of gene function. This allows for the investigation of downstream effects on mitochondrial morphology, respiration, and signaling pathways, providing a valuable tool to understand cellular energy homeostasis, neurodegeneration, and metabolic diseases.
The scientific importance of ATAD3B Gene Knockout Cell Lines lies in their application in both research and clinical settings. They provide insights into mitochondrial dysfunction, which is implicated in a variety of conditions, including neurodegenerative diseases, metabolic syndromes, and certain cancers. By studying the phenotypic alterations resulting from ATAD3B knockout, researchers can identify potential therapeutic targets or biomarkers for early diagnosis and intervention.
One of the most significant advantages of using ATAD3B Gene Knockout Cell Lines is the specificity and precision afforded by CRISPR technology. Unlike traditional methods that may result in off-target effects or unintended mutations, our cell lines provide reliability and reproducibility in experimental results. This unique selling point ensures that researchers can confidently draw conclusions based on the precise knockout of the ATAD3B gene.
For researchers and clinicians focused on mitochondrial biology and related illnesses, the value of ATAD3B Gene Knockout Cell Lines cannot be overstated. They pave the way for groundbreaking discoveries that may advance the understanding of disease mechanisms and facilitate the development of novel therapeutic strategies.
Our company specializes in providing high-quality, validated biological products designed to support cutting-edge research. With a commitment to scientific excellence and comprehensive support, we stand as a trusted partner in your pursuit of innovative solutions in biotechnology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.